Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine in Generalized Anxiety Disorder
NCT01975480Phase 4Completed
- Sponsor
- START Clinic for Mood and Anxiety Disorders
- Start
- Jan 2013
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desvenlafaxine in generalized anxiety disorder (GAD), sponsored by START Clinic for Mood and Anxiety Disorders. Started Jan 2013; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT01975480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975480.